…from the Hill….
Oxford University on Friday announced the launch of a new study measuring the safety and efficacy of its coronavirus vaccine in children.
The university, which developed the vaccine with AstraZeneca, said in a press release that the trial will include children as young as 6 years old, with approximately 300 volunteers participating in the study.
Andrew Pollard, the trial’s chief investigator, said in a statement, “While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.” …